Skip to content

Monica J Barratt

34 papers in the library · 411 citations · publishing 2013-2026

Papers

Sort Most recent Most cited

The Australian Ayahuasca Dietero Networks: Culture, Community, and Practices

Contemporary Drug Problems August 11, 2026 Alana Roy, M.l. Williams, Kimberley Day et al.

Alternative healthcare practices using psychedelic “plant medicines,” such as ayahuasca, challenge current prohibition and mainstream healthcare frameworks. Despite the criminalization of ayahuasca's active component, N,N-dimethyltryptamine (DMT), Australian ayahuasca dietero networks have developed sophisticated healthcare systems with systematic assessment processes, safety mechanisms, and...

Self-treatment of psychiatric conditions using ketamine: Patterns, characteristics, and retrospective insights.

Journal of Psychopharmacology June 1, 2026 Gabrielle Smith, Timothy Piatkowski, Jason Ferris et al. 1 citation

While research on novel therapeutic applications of ketamine is expanding, particularly in controlled settings, there is limited exploration of its consumption related to self-treatment of psychiatric conditions. This study investigated the characteristics of people who use ketamine and psychedelics for self-treatment of psychiatric conditions, providing insight into patterns of use within this...

“You can only take your clients as far as you’ve been yourself”: examining the intersections between psychedelic-assisted therapy, lived-living experience, and clinical practice

Drugs Education Prevention and Policy March 22, 2026 Jordan J. Negrine, Stephen Bright, Monica J Barratt et al.

Background Following Australia’s landmark 2023 decision to approve psilocybin and MDMA for clinical use, psychedelic-assisted therapy (PAT) is beginning to emerge within regulated mental health settings. This study investigates psychologists’ views on the relevance of psychedelic therapists’ lived-living experience (LLE) with psychedelics. While discussion around LLE is growing, little is known...

DOI: 10.1080/09687637.2026.2645025 (opens in new tab) Clinical practice Qualitative research Medline Applied psychology +2

Psychedelics and Sexual Trauma: Effects on Communication and Emotional Connection.

The Journal of Sex Research January 16, 2026 Mason Levey, Benjamin Bonenti, Timothy Piatkowski et al.

Psychedelics are theorized to enhance emotional openness and interpersonal attunement, but their effects in sexual contexts - particularly among those with a history of sexual trauma - remain underexplored. This study investigated whether individuals who had used psychedelics to cope with or overcome sexual trauma (Psy-CST) reported different experiences of sexual communication and emotional...

Exploring psychedelic experiences among people who regularly use methamphetamine: Findings from an international survey.

Drug and Alcohol Dependence July 1, 2025 Dilara Bahceci, Krista J. Siefried, Maureen Steele et al.

Methamphetamine use disorder, associated with significant morbidity and mortality, has limited effective treatments. Psychedelic-assisted psychotherapy shows promise, but data on its safety and efficacy in this population are limited. This exploratory study describes the demographic, substance use, and mental health characteristics of people who used methamphetamine and psychedelics and the...

"Wood-lover paralysis": Describing a toxidrome with symptoms of weakness caused by some lignicolous "wood-loving" Psilocybe mushrooms.

Toxicon June 7, 2025 Simon A Beck, Caine Barlow, Liam Engel et al. 4 citations

Psilocybin-containing mushrooms have long been used for their psychoactive effects, but emerging evidence suggests that certain lignicolous ("wood-loving") species may also induce a distinct toxidrome known as "wood-lover paralysis" (WLP). WLP is characterised by transient weakness following mushroom ingestion, but its aetiology and prevalence remain poorly understood. In this paper, we present...

Risk communication about high-dose MDMA: Impact of a hypothetical drug alert on future MDMA use.

Drug and Alcohol Review May 1, 2025 Joel Keygan, Breanna Willoughby, Raimondo Bruno et al. 1 citation

Despite high-dose 3,4-methylenedioxymethamphetamine (MDMA) drug alerts being distributed, no research has been conducted as to changes in use in response. This study aimed to determine if: (i) high-dose MDMA drug alerts, and (ii) varied descriptions of dose, effects and actions to reduce harm were associated with intentions to reduce the initial MDMA dose in a hypothetical scenario. Australians...

DOI: 10.1111/dar.14037 (opens in new tab) Full text (opens in new tab) Drug safety alerts MDMA/Ecstasy/Molly Public health interventions Behaviour change +3

Ketamine use in a large global sample: Characteristics, patterns of use and emergency medical treatment.

Journal of Psychopharmacology 2025 Karen P Barrios, Dean J Connolly, Jason Ferris et al. 17 citations

Ketamine's popularity has surged globally in the past decade, especially among young men. Emergency department visits due to its toxicity remain relatively rare, often linked to co-occurring use of other substances. Using data from the Global Drug Survey (GDS) 2018, this study explored the correlates associated with lifetime and past-year ketamine use, and estimated the socio-demographic...

DOI: 10.1177/02698811241273850 (opens in new tab) Full text (opens in new tab) Emergency medical treatment Global drug survey Ketamine use patterns Past-year ketamine use +7

Comparison of strength and adulteration between illicit drugs obtained from cryptomarkets versus off-line.

Addiction 2025 Leigh Coney, Amy Peacock, Daan van der Gouwe et al. 8 citations

Drugs sold on cryptomarkets are thought to have lower levels of adulteration and higher strength compared with those sourced off-line. The present study aimed to determine whether cryptomarket and off-line-sourced 3,4-methylenedioxy-N-methamphetamine (MDMA), cocaine, amphetamine, methamphetamine and lysergic acid diethylamide (LSD) differed in adulteration and strength. A between-groups design...

DOI: 10.1111/add.16665 (opens in new tab) Full text (opens in new tab) Adulteration Illicit drugs Drug checking Drug quality +8

Tripping into the unknown: Exploring the experiences of first-time LSD users through global drug survey insights.

Journal of Psychopharmacology August 1, 2024 Luke Baxter, Cheneal Puljević, Tim Piatkowski et al. 3 citations

The recreational use of LSD, a synthetic psychedelic drug, has surged in recent years, coinciding with a renewed research focus on its potential psychotherapeutic properties. This study aims to describe the experiences and perceptions of individuals engaging in LSD use for the first time, derived from a large international sample. This study utilised 2018 Global Drug Survey data collected from...

From chaos to kaleidoscope: Exploring factors in psychedelic self-treatment for mental health conditions.

Journal of Psychopharmacology July 29, 2024 Claire Walker, Timothy Piatkowski, Jason Ferris et al. 4 citations

INTRODUCTION: This study explores how individuals self-treat psychiatric conditions with psychedelics outside medical guidance bridging the gap in understanding unregulated therapeutic use. AIMS: The primary objective was to extract specific factors underlying the effects of psychedelics, exploring their relationship with the need for medication, particularly for mental health conditions like...

DOI: 10.1177/02698811241265762 (opens in new tab) Full text (opens in new tab) Mental-health Psychedelics Self-treatment Depression-anxiety +1

Adulteration and substitution of drugs purchased in Australia from cryptomarkets: An analysis of Test4Pay

Drug and Alcohol Review March 4, 2024 Monica J Barratt, Matthew Ball, Gabriel T. W. Wong et al. 18 citations

INTRODUCTION: Prohibited drugs in unregulated markets may be adulterated, resulting in increased risks for people who use drugs. This study investigated levels of drug adulteration and substitution of drugs purchased in Australia from cryptomarkets. METHODS: Data were collected from a darknet forum called Test4Pay from 1 September 2022 to 23 August 2023. Posts were included if they reported the...

The relationship between cryptomarket drug purchase, social networks and adverse drug events: A cross-sectional study.

International Journal of Drug Policy 2024 Leigh Coney, Amy Peacock, Aili Malm et al. 2 citations

Drug use and trading are typically social activities; however, supply through cryptomarkets can occur without any in-person social contact. People who use drugs alone may be at higher risk of experiencing harms, for example, due to lack of others who may call for emergency assistance. Alternatively, cryptomarkets may be a source of harm reduction information and drugs with better-known content...

DOI: 10.1016/j.drugpo.2023.104258 (opens in new tab) Full text (opens in new tab) Adverse drug events Cryptomarkets Social network analysis Social networks +4

Drug adulteration and substitution within Australian cryptomarkets: An analysis of Test4Pay

September 21, 2023 Monica J Barratt, Matthew Ball, Gabriel T. W. Wong et al. 1 citation

Prohibited drugs in unregulated markets are often adulterated, resulting in increased risks for consumers. This study investigated levels of drug adulteration and substitution in drugs purchased by Australians from cryptomarkets.Methods.Data were collected from the Dread subforum /d/Test4Pay from 1/9/2022 to 23/8/2023. Posts were included if they reported the results of drug samples submitted...

Mescaline, Peyote and San Pedro: Is sustainability important for cacti consumers?

Journal of Psychedelic Studies August 19, 2023 Liam Engel, Monica J Barratt, Jason Ferris et al. 7 citations

Abstract Background and Aims Both Peyote and San Pedro cacti contain mescaline, a classical psychedelic eliciting mystical and visual effects, but only Peyote is a vulnerable species. We sought to address the questions 1; do people who use Peyote substitute with San Pedro, and vice versa, and; 2. how popular is the use of wild harvested mescaline cactus compared with the use of cultivated...

Identifying new psychoactive substances (NPS) using drug checking services: An innovative observational study design

Research Square September 23, 2022 M. Grifell, Guillem Mir, Roger Estelrich-Azubide et al. preprint

Abstract Background Despite the proliferation of new psychoactive substances (NPS) in recent years, there are many gaps in our understanding of the phenomena. Current methodologies still fail to provide timely and scientifically reliable knowledge between controlled trials and online data reports that lack analytical confirmation of the reported substances. This study tests a new online,...

Community-led guerrilla drug checking in response to deaths from adulterated MDMA in Victoria, Australia

Drugs, Habits and Social Policy August 17, 2022 Monica J Barratt, Stephen Bright, Ash R. Blackwell

Purpose Following deaths and hospitalisations in Melbourne, Victoria, Australia, related to the unwitting consumption of a combination of 25C-NBOMe and 4-FA, a community-led unauthorised drug checking service was rapidly established at a subsequent music festival. We aim to demonstrate the value of community-led drug checking, even when conducted in less-than-ideal conditions, by describing...

Who uses digital drugs? An international survey of 'binaural beat' consumers.

Drug and Alcohol Review July 1, 2022 Monica J Barratt, Alexia Maddox, Naomi Smith et al. 19 citations

Digital drugs, or binaural beats claimed to elicit specific cognitive or emotional states, are a phenomenon about which little is known. In this brief report, we describe demographic and drug use correlates of binaural beat use, patterns of use, reasons for use and methods of access. The Global Drug Survey 2021 was translated into 11 languages; 30 896 responses were gathered from 22 countries....

DOI: 10.1111/dar.13464 (opens in new tab) Full text (opens in new tab) Cross-sectional study Hallucinogen Illicit drug Music +1

Clinical withdrawal symptom profile of synthetic cannabinoid receptor agonists and comparison of effects with high potency cannabis.

Psychopharmacology May 1, 2022 Sam Craft, Jason Ferris, Monica J Barratt et al. 19 citations

Synthetic cannabinoid receptor agonists (SCRAs) may be used as an alternative to natural cannabis; however, they may carry a greater risk of problematic use and withdrawal. This study aimed to characterise the withdrawal symptom profile of SCRAs and compare their profile of effect with high-potency herbal cannabis. Global Drug Survey data (2015 and 2016) were used to access a clinically...

Profile and correlates of colorimetric reagent kit use among people who use ecstasy/MDMA and other illegal stimulants in Australia.

International Journal of Drug Policy November 1, 2021 Amy Peacock, Daisy Gibbs, Olivia Price et al. 12 citations

Colorimetric reagent kits can provide information about the compounds present in drug samples. This study aimed to identify patterns and correlates of colorimetric reagent kit use, as well as behavioural outcomes of testing, amongst people who use illegal stimulants in a context that lacks permanent government-sanctioned drug checking services. Australians residing in capital cities who...

Microdosing psychedelics: Subjective benefits and challenges, substance testing behavior, and the relevance of intention

Journal of Psychopharmacology October 8, 2020 Rotem Petranker, Thomas Anderson, Larissa J. Maier et al. 57 citations

Background: Microdosing psychedelics is the practice of taking small, sub-hallucinogenic doses of lysergic acid diethylamide or psilocybin-containing mushrooms. Despite its surging popularity, little is known about the specific intentions to start microdosing and the effects of this practice. Aims: First, we aimed to replicate previous findings regarding the subjective benefits and challenges...

Global Drug Survey

April 12, 2020 Rotem Petranker, Thomas Anderson, Larissa J. Maier et al. 14 citations preprint

Background: Microdosing psychedelics – the practice of taking small, sub-hallucinogenic doses of substances like LSD or psilocybin-containing mushrooms – is becoming increasingly popular. Despite its surging popularity, little is known about the effects of this practice. Aims: This research had three main aims. First, we attempted to replicate previous findings regarding the subjective benefits...

Prevalence of reagent test-kit use and perceptions of purity among ecstasy users in an electronic dance music scene in New York City.

Drug and Alcohol Review January 2019 Joseph J Palamar, Monica J Barratt

Ecstasy users in the electronic dance music scene are at high risk for using ecstasy adulterated with new psychoactive substances and/or methamphetamine. We examined self-reported testing of ecstasy among users in this scene. We surveyed individuals (aged 18-40 years) entering electronic dance music parties in New York City in 2017. Past-year ecstasy users (n = 351) were asked if they had...

Double dropping down under: Correlates of simultaneous consumption of two ecstasy pills in a sample of Australian outdoor music festival attendees.

Drug and Alcohol Review November 2018 Jodie Grigg, Monica J Barratt, Simon Lenton

The term 'double dropping' refers to a person consuming two drugs simultaneously, typically two ecstasy pills. This practice has been reported in numerous countries, including Australia; however, the prevalence and correlates of double dropping among ecstasy users is unknown. Double dropping is particularly risky when adulteration of 'ecstasy' with novel substances and higher dosages of MDMA in...

Harm reduction strategies related to dosing and their relation to harms among festival attendees who use multiple drugs

Drug and Alcohol Review October 9, 2018 F. Fernández-Calderón, C. Díaz-Batanero, Monica J Barratt et al.

Introduction and Aims: Polysubstance users are a high-risk population for negative health-related consequences. Although some studies have described harm reduction strategies adopted by polysubstance users, studies have not examined their effectiveness in minimising health-related consequences. We aimed to identify dosing-related harm reduction strategies in a sample of polysubstance-using...